MarkAHullMD

PubMed

• 4 citations
  Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
  E Walsh, Colin J Rees, M Gill, CE Parker, Roisin Bevan, SL Perry, Yvonne Bury, S Mills, D. M. Bradburn, MG Bramble, Mark A. Hull> ;British Journal of Cancer. 2016 Jul 12
• 1 citations
  Successful delivery of clinical gastroenterology studies in the UK
  Mark A. Hull, John McLaughlin> ;Gut. 2015 May 1
• 38 citations
  Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers
  Gill, MG Bramble, Mark A. Hull, S. J. Mills, E Morris, D. M. Bradburn, Yvonne Bury, CE Parker, Thomas J W Lee, Colin J Rees> ;British Journal of Cancer. 2014 Nov 25
• 76 citations
  Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid
  Andrew J. Cockbain, Milene Volpato, Amanda D. Race, Alessandra Munarini, Chiara Fazio, Andrea Belluzzi, Paul M. Loadman, Giles J. Toogood, Mark A. Hull> ;Gut. 2014 Nov 1
• 13 citations
  Obesity and colorectal cancer
  Mark A. Hull, Jesper Lagergren> ;Gut. 2014 Jan 1
• 17 citations
  Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass.
  Prashant Kant, Sarah L. Perry, Simon P. Dexter, Amanda D. Race, Paul M. Loadman, Mark A. Hull> ;Obesity. 2014 Jan 1
• 93 citations
  MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion
  Eldo T. Verghese, Ruth Drury, Caroline A. Green, Deborah L. Holliday, Xiaomei Lu, Claire Nash, Valerie Speirs, James L. Thorne, Helene Thygesen, Alexandre Zougman, Mar...> ;The Journal of Pathology. 2013 Nov 1
• 18 citations
  Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human...
  Nicola Ingram, Emma Northwood, SL Perry, Gemma Marston, Helen Snowden, John C. Taylor, Nigel Scott, D. Timothy Bishop, P. Louise Coletta, Mark A. Hull> ;Carcinogenesis. 2013 Oct 1
• 1 citations
  Commentary: the association between low‐dose aspirin use and the incidence of colorectal cancer
  Nicholas E Burr, Mark A. Hull> ;Alimentary Pharmacology & Therapeutics. 2013 Sep 1
• 8 citations
  High-frequency ultrasound for in vivo measurement of colon wall thickness in mice.
  Mostafa Abdelrahman, Gemma Marston, Mark A. Hull, Alexander F. Markham, Pamela F. Jones, J. Anthony Evans, P. Louise Coletta> ;Ultrasound in Medicine & Biology. 2012 Mar 1
• 200 citations
  Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
  Andrew T. Chan, Nadir Arber, John Burn, Whay Kuang Chia, Peter Creighton Elwood, Mark A. Hull, Richard F A Logan, Peter M. Rothwell, Karsten Schrör, John A. Baron> ;Cancer Prevention Research. 2012 Feb 1
• 14 citations
  Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
  Thomas J W Lee, Mark A. Hull, P T Rajasekhar, Gayle Clifford, Marylyn D. Ritchie, Peter James, Richard J. Q. McNally, Rutter, Colin J Rees> ;Digestion. 2012 Jan 1
• 200 citations
  Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer
  A J Cockbain, Giles J. Toogood, Mark A. Hull> ;Gut. 2012 Jan 1
• 7 citations
  Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice.
  Lorraine Marsh, P. Louise Coletta, Mark A. Hull, Peter Selby, Simon R. Carding> ;International Journal of Oncology. 2011 Aug 29
• Chemoprevention in gastroenterology
  Mark A. Hull, Richard F A Logan> ;Best Practice & Research. Clinical Gastroenterology. 2011 Aug 1
• 42 citations
  Omega-3 polyunsaturated fatty acids.
  Mark A. Hull> ;Best Practice & Research. Clinical Gastroenterology. 2011 Aug 1
• 37 citations
  Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity:...
  Prashant Kant, Anita Sainsbury, Karen Ruth Reed, S. G. Pollard, Nigel Scott, Alan Richard Clarke, PL Coletta, Mark A. Hull> ;Gut. 2011 Jul 1
• 92 citations
  Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer
  Prashant Kant, Mark A. Hull> ;Nature Reviews. Gastroenterology & Hepatology. 2011 Apr 1
• 7 citations
  Colonoscopy for colonic wall thickening at computed tomography: a worthwhile pursuit?
  Brian D Nicholson, Rachel Hyland, Bjorn J. Rembacken, Mark Denyer, Mark A. Hull, Damian Tolan> ;Surgical Endoscopy. 2011 Feb 27
• 54 citations
  Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells
  Gillian Hawcroft, Paul M. Loadman, Andrea Belluzzi, Mark A. Hull> ;Neoplasia. 2010 Aug 1
• 8 citations
  Atherosclerosis and colorectal carcinogenesis: shared risk factors or common pathogenesis?
  Mark A. Hull, Prashant Kant> ;Digestion. 2010 Jan 1
• 149 citations
  Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis
  Nicholas J West, Susan K. Clark, Robin K. S. Phillips, John Hutchinson, Roger J. Leicester, Andrea Belluzzi, Mark A. Hull> ;Gut. 2010 Jan 1
• 18 citations
  Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas
  Richard Cuthbert, J.M. Wilson, Nigel Scott, PL Coletta, Mark A. Hull> ;European Journal of Cancer. 2009 Jun 1
• 8 citations
  Effect of weight loss on proinflammatory state of mononuclear cells in obese women.
  Prashant Kant, Mark A. Hull> ;Obesity. 2009 May 1
• 29 citations
  Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse
  CH Burgoyne, Sarah L. Field, Andrew K. Brown, Elizabeth M A Hensor, Anne English, S L Bingham, R J Verburg, Ursula Fearon, CA Lawson, P J Hamlin, Liz Straszynski, Doug...> ;Annals of the Rheumatic Diseases. 2008 Jun 1
• Join now to see all